Advertisement

Issue Highlights

        As clinicians, we are often presented with usually challenging cases. These are cases where the literature does not provide a clear answer and we are forced to consult with our colleagues and make the best decision for the patient with the information on hand. With that in mind, we debut a new feature in the Red Journal where we attempt to answer some of radiation oncology’s most challenging scenarios. With the “Gray Zone,” we present a difficult case along with varied opinions from around the world. Please read the vignettes and share your own opinion afterwards on Twitter using the hashtag #gyzone.
        To read this article in full you will need to make a payment
        ASTRO Member Login
        ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

        Purchase one-time access:

        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect

        Comments

        Commenting Guidelines

        To submit a comment for a journal article, please use the space above and note the following:

        • We will review submitted comments as soon as possible, striving for within two business days.
        • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
        • We require that commenters identify themselves with names and affiliations.
        • Comments must be in compliance with our Terms & Conditions.
        • Comments are not peer-reviewed.